{"id":"antiplatelet-monotherapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Bruising"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiplatelet agents work by interfering with platelet activation and clumping through various mechanisms such as cyclooxygenase inhibition, ADP receptor antagonism, or phosphodiesterase inhibition. This prevents thrombus formation and reduces the risk of cardiovascular events including myocardial infarction and stroke. The specific mechanism depends on the particular antiplatelet agent being used in the monotherapy regimen.","oneSentence":"Antiplatelet monotherapy inhibits platelet aggregation to reduce thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:02:01.148Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Secondary prevention of cardiovascular events"},{"name":"Acute coronary syndrome"},{"name":"Stroke prevention"}]},"trialDetails":[{"nctId":"NCT07480629","phase":"","title":"The 10-Year Extended Follow-up of the DACAB Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Ruijin Hospital","startDate":"2026-03-15","conditions":"Coronary Artery Disease, CABG, Antiplatelet Therapy of Coronary Artery Bypass","enrollment":500},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT05681702","phase":"PHASE4","title":"Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI","status":"RECRUITING","sponsor":"University of Florida","startDate":"2023-02-15","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT06916520","phase":"PHASE4","title":"Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)","status":"RECRUITING","sponsor":"J.P.S Henriques","startDate":"2025-11-13","conditions":"Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)","enrollment":300},{"nctId":"NCT03950076","phase":"PHASE4","title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2019-09-20","conditions":"Intracranial Hemorrhages, Atrial Fibrillation","enrollment":948},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT06588595","phase":"PHASE4","title":"The Switching Antiplatelet-9 (SWAP-9) Study","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-11-01","conditions":"Coronary Arterial Disease (CAD)","enrollment":90},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT06691191","phase":"PHASE4","title":"Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-01-08","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT07374718","phase":"NA","title":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-03-01","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)","enrollment":468},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT07286110","phase":"PHASE1","title":"Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-12-30","conditions":"Moyamoya Disease, Moyamoya Syndrome","enrollment":66},{"nctId":"NCT07198529","phase":"NA","title":"OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina","status":"RECRUITING","sponsor":"Korea University Guro Hospital","startDate":"2025-09-30","conditions":"Stable Angina, Coronary Artery Disease","enrollment":130},{"nctId":"NCT04624854","phase":"PHASE4","title":"Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2020-10-28","conditions":"Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome","enrollment":8250},{"nctId":"NCT06742931","phase":"NA","title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-04-07","conditions":"Chronic Coronary Syndrome","enrollment":1200},{"nctId":"NCT06336174","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-11-01","conditions":"Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT07164859","phase":"PHASE3","title":"Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI","status":"NOT_YET_RECRUITING","sponsor":"Vincent ROULE","startDate":"2025-10","conditions":"Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI), Antiplatelet Therapy","enrollment":1700},{"nctId":"NCT06665919","phase":"NA","title":"The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models","status":"COMPLETED","sponsor":"Vistamedi Ltd.","startDate":"2023-06-15","conditions":"Coronary Artery Disease, Clopidogrel Resistance, Coronary Thrombosis","enrollment":283},{"nctId":"NCT05732701","phase":"NA","title":"Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-06-27","conditions":"Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease","enrollment":2788},{"nctId":"NCT06216821","phase":"NA","title":"OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time","status":"RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2024-07-02","conditions":"Acute Coronary Syndrome","enrollment":3490},{"nctId":"NCT03431142","phase":"PHASE4","title":"Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2018-02-12","conditions":"Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage","enrollment":7758},{"nctId":"NCT07125417","phase":"PHASE4","title":"Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure","status":"RECRUITING","sponsor":"OCEAN-SHD Study Group","startDate":"2025-05-29","conditions":"Nonvalvular Atrial Fibrillation, Aspirin, Non-Antithrombotic Therapy","enrollment":500},{"nctId":"NCT04753749","phase":"NA","title":"Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy","status":"COMPLETED","sponsor":"MicroPort CRM","startDate":"2021-03-25","conditions":"Myocardial Infarction, Acute, Coronary Artery Disease","enrollment":2248},{"nctId":"NCT06710262","phase":"","title":"T-TAS® wS Method Comparison","status":"COMPLETED","sponsor":"Hikari Dx, Inc.","startDate":"2024-08-21","conditions":"Antiplatelet Therapy, Healthy Donors, Von Willebrand Disease (VWD)","enrollment":115},{"nctId":"NCT07080684","phase":"PHASE4","title":"Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Messina","startDate":"2025-12-01","conditions":"Chronic Coronary Syndrome","enrollment":1000},{"nctId":"NCT06981390","phase":"NA","title":"Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG","status":"RECRUITING","sponsor":"Kexiang Liu, MD","startDate":"2025-02-01","conditions":"Coronary Artery Disease, Coronary Artery Bypass Grafting, Saphenous Vein","enrollment":300},{"nctId":"NCT04010955","phase":"","title":"Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asan Medical Center","startDate":"2019-10-08","conditions":"Acute Ischemic Stroke, Atrial Fibrillation, Extracranial Atherosclerosis","enrollment":1200},{"nctId":"NCT04360720","phase":"PHASE3","title":"Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2020-10-15","conditions":"Acute Coronary Syndrome","enrollment":3410},{"nctId":"NCT06509893","phase":"PHASE4","title":"Ticagrelore Alone Post PCI","status":"RECRUITING","sponsor":"Shiraz University of Medical Sciences","startDate":"2024-08-01","conditions":"Coronary Artery Disease","enrollment":5400},{"nctId":"NCT05066789","phase":"PHASE4","title":"CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4","status":"TERMINATED","sponsor":"Samsung Medical Center","startDate":"2022-01-17","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT06763744","phase":"PHASE4","title":"Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR","status":"NOT_YET_RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-06-01","conditions":"Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), High Bleeding Risk","enrollment":3000},{"nctId":"NCT05767723","phase":"PHASE4","title":"Platelet Sub-study of the Neomindset Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2023-02-06","conditions":"Acute Coronary Syndrome","enrollment":48},{"nctId":"NCT04484259","phase":"PHASE4","title":"Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease","enrollment":105},{"nctId":"NCT06899399","phase":"NA","title":"Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-18","conditions":"Asymptomatic Carotid Artery Stenosis","enrollment":982},{"nctId":"NCT04522102","phase":"PHASE3","title":"Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase","status":"COMPLETED","sponsor":"The George Institute for Global Health, China","startDate":"2021-09-03","conditions":"Intracerebral Hemorrhage","enrollment":80},{"nctId":"NCT06881901","phase":"","title":"Antiplatelet Strategy for CCS Patients Undergoing CABG","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-01-01","conditions":"Chronic Coronary Syndrome, Coronary Artery Bypass Graft CABG","enrollment":29898},{"nctId":"NCT06866665","phase":"NA","title":"Antithrombotic Strategy for AF Patients With High Risk CAD","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2025-03","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":1400},{"nctId":"NCT03447379","phase":"NA","title":"Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2017-12-15","conditions":"Coronary Artery Disease","enrollment":1452},{"nctId":"NCT04418479","phase":"PHASE4","title":"SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3","status":"COMPLETED","sponsor":"Joo-Yong Hahn","startDate":"2020-08-10","conditions":"Coronary Artery Disease","enrollment":5506},{"nctId":"NCT03729401","phase":"PHASE4","title":"Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND","status":"SUSPENDED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2019-08-22","conditions":"Coronary Artery Disease, Myocardial Infarction","enrollment":390},{"nctId":"NCT06715930","phase":"","title":"Nomogram for Predicting In-stent Stenosis After Pipeline Embolization Device Treatment in Patients with Intracranial Aneurysm","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2016-04-01","conditions":"Intracranial Aneurysm","enrollment":1500},{"nctId":"NCT05763862","phase":"NA","title":"Genotype Guided Antiplatelet Therapy in Ischemic Stroke","status":"RECRUITING","sponsor":"National Neuroscience Institute","startDate":"2023-04-24","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":350},{"nctId":"NCT03947229","phase":"PHASE4","title":"A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2019-08-14","conditions":"Coronary Artery Disease, DES","enrollment":3200},{"nctId":"NCT05320926","phase":"NA","title":"Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2022-07-26","conditions":"Ischemic Heart Disease","enrollment":3744},{"nctId":"NCT06648720","phase":"NA","title":"Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Ho Chi Minh City (UMC)","startDate":"2025-03-01","conditions":"Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI), Intravascular Ultrasound","enrollment":3566},{"nctId":"NCT06613191","phase":"PHASE4","title":"Colonoscopy and Antiplatelet Therapy Trial","status":"NOT_YET_RECRUITING","sponsor":"Ochsner Health System","startDate":"2024-10-01","conditions":"Coronary Arterial Disease (CAD), Peripheral Vascular Disease","enrollment":100},{"nctId":"NCT05986968","phase":"NA","title":"Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-07-06","conditions":"ST Elevation Myocardial Infarction","enrollment":200},{"nctId":"NCT05117866","phase":"NA","title":"Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Meditrix Corp","startDate":"2020-09-15","conditions":"Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome","enrollment":307},{"nctId":"NCT02939872","phase":"PHASE4","title":"Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2017-03-09","conditions":"Percutaneous Transluminal Coronary Angioplasty, Coronary Disease","enrollment":238},{"nctId":"NCT02619760","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2015-12","conditions":"Coronary Artery Disease","enrollment":3045},{"nctId":"NCT04609111","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2021-01-29","conditions":"Acute Coronary Syndrome","enrollment":6002},{"nctId":"NCT03462498","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2018-04-02","conditions":"Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease","enrollment":3008},{"nctId":"NCT02830152","phase":"NA","title":"Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2017-05-03","conditions":"Atrial Fibrillation, Stroke, Intracerebral Hemorrhage","enrollment":750},{"nctId":"NCT03718559","phase":"PHASE4","title":"Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Gi-Byoung Nam","startDate":"2019-05-14","conditions":"Atrial Fibrillation, Coronary Artery Disease, Stable Angina","enrollment":1040},{"nctId":"NCT06400940","phase":"PHASE4","title":"Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2023-08-17","conditions":"Intracranial Aneurysm","enrollment":640},{"nctId":"NCT05015699","phase":"NA","title":"A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI","status":"WITHDRAWN","sponsor":"Sino Medical Sciences Technology Inc.","startDate":"2021-09","conditions":"Coronary Artery Disease","enrollment":""},{"nctId":"NCT03119012","phase":"PHASE4","title":"P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold","status":"TERMINATED","sponsor":"Samsung Medical Center","startDate":"2017-04-19","conditions":"Coronary Artery Disease, Stents, Atherosclerosis","enrollment":25},{"nctId":"NCT06283888","phase":"PHASE4","title":"CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Zunyi Medical College","startDate":"2024-04-01","conditions":"ACS - Acute Coronary Syndrome, CYP2C19 Polymorphism","enrollment":1200},{"nctId":"NCT05262803","phase":"PHASE4","title":"Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction","status":"RECRUITING","sponsor":"Rikke Sorensen","startDate":"2022-06-17","conditions":"Myocardial Infarction","enrollment":2808},{"nctId":"NCT06015477","phase":"NA","title":"Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2024-01-01","conditions":"Intracranial Aneurysm, Stent Complication","enrollment":180},{"nctId":"NCT06301776","phase":"NA","title":"A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of China Medical University","startDate":"2023-12-05","conditions":"Brain Disease, Vertebral Artery Stenosis","enrollment":560},{"nctId":"NCT05223335","phase":"PHASE4","title":"Clopidogrel Monotherapy in Patients With High Bleeding Risk","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-03-29","conditions":"Bleeding Complications","enrollment":98},{"nctId":"NCT04923191","phase":"NA","title":"The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent","status":"RECRUITING","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2021-11-12","conditions":"Coronary Artery Disease","enrollment":2540},{"nctId":"NCT06103266","phase":"PHASE4","title":"Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention","status":"UNKNOWN","sponsor":"J.P.S Henriques","startDate":"2024-01","conditions":"Atrial Fibrillation, Coronary Artery Disease","enrollment":50},{"nctId":"NCT05936606","phase":"NA","title":"Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-08-16","conditions":"Coronary Artery Disease","enrollment":3434},{"nctId":"NCT04718025","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Collegium Medicum w Bydgoszczy","startDate":"2022-02-07","conditions":"STEMI, NSTEMI, Unstable Angina","enrollment":4500},{"nctId":"NCT05770674","phase":"NA","title":"Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES","status":"UNKNOWN","sponsor":"Kiyuk Chang","startDate":"2022-04-01","conditions":"Coronary Artery Disease","enrollment":2186},{"nctId":"NCT04766437","phase":"PHASE2","title":"Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-02-19","conditions":"Non ST Segment Elevation Acute Coronary Syndrome","enrollment":75},{"nctId":"NCT05709626","phase":"PHASE4","title":"PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction","status":"RECRUITING","sponsor":"Kindai University","startDate":"2023-02-28","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":2258},{"nctId":"NCT05567536","phase":"","title":"Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2014-03-01","conditions":"Coronary Artery Disease, Atheroscleroses, Coronary","enrollment":5530},{"nctId":"NCT04032665","phase":"","title":"Reveal Transition - A Mechanistic Study in Transition / Stabilized Phase of CAD","status":"WITHDRAWN","sponsor":"University Hospital Tuebingen","startDate":"2019-07-23","conditions":"Cardiovascular Diseases","enrollment":""},{"nctId":"NCT03198741","phase":"PHASE4","title":"Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2017-07-13","conditions":"Gastrointestinal Injury, Ischemic Heart Disease","enrollment":783},{"nctId":"NCT03815175","phase":"NA","title":"XIENCE 28 USA Study","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2019-02-25","conditions":"Bleeding Disorder, Ischemic Stroke, Hemorrhagic Stroke","enrollment":1605},{"nctId":"NCT05233124","phase":"PHASE2","title":"Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-09-01","conditions":"Acute Coronary Syndrome, Coronary Artery Ectasia","enrollment":60},{"nctId":"NCT04850001","phase":"","title":"Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study","status":"UNKNOWN","sponsor":"Anhui Medical University","startDate":"2020-09-10","conditions":"Magnetic Resonance Imaging, Asymptomatic Intracranial Stenosis, Medical Treatment","enrollment":40},{"nctId":"NCT02044250","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-02","conditions":"Coronary Heart Disease","enrollment":5530},{"nctId":"NCT02770274","phase":"PHASE3","title":"Cilostazol Following Peripheral Endovascular Procedures","status":"UNKNOWN","sponsor":"Attikon Hospital","startDate":"2016-12","conditions":"Peripheral Arterial Disease","enrollment":200},{"nctId":"NCT04570345","phase":"PHASE4","title":"3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI","status":"UNKNOWN","sponsor":"Dong-A University","startDate":"2021-01-01","conditions":"ST Elevation Myocardial Infarction","enrollment":1002},{"nctId":"NCT03287167","phase":"PHASE4","title":"Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Shanghai MicroPort Medical (Group) Co., Ltd.","startDate":"2019-06-01","conditions":"Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention","enrollment":1720},{"nctId":"NCT03231059","phase":"","title":"GLOBAL LEADERS Adjudication Sub-Study","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2017-06-01","conditions":"Coronary Artery Disease, Platelet-aggregation Inhibitors","enrollment":7365},{"nctId":"NCT02247128","phase":"PHASE4","title":"Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2014-01","conditions":"Aortic Valve Disease, Myocardial Infarction, Stroke","enrollment":1016},{"nctId":"NCT03621020","phase":"","title":"Clinical Performance Evaluation of T-TAS 01 PL Chip","status":"COMPLETED","sponsor":"Hikari Dx, Inc.","startDate":"2018-09-01","conditions":"Platelet Dysfunction, Von Willebrand Diseases, Healthy","enrollment":307},{"nctId":"NCT02833948","phase":"PHASE3","title":"Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2016-05","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Valve Diseases","enrollment":231},{"nctId":"NCT01995370","phase":"PHASE4","title":"Cilostazol Stroke Prevention Study for Antiplatelet Combination","status":"COMPLETED","sponsor":"Japan Cardiovascular Research Foundation","startDate":"2013-12-13","conditions":"Noncardioembolic Cerebral Infarction","enrollment":1884},{"nctId":"NCT03881943","phase":"PHASE4","title":"Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2017-01","conditions":"Acute Coronary Syndrome","enrollment":200},{"nctId":"NCT02079194","phase":"NA","title":"Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2014-03-18","conditions":"Coronary Artery Disease","enrollment":3000},{"nctId":"NCT02494895","phase":"PHASE4","title":"Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-08-01","conditions":"Acute Coronary Syndrome","enrollment":3056},{"nctId":"NCT03184805","phase":"NA","title":"STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation","status":"TERMINATED","sponsor":"Yonsei University","startDate":"2017-06-23","conditions":"Coronary Artery Disease","enrollment":140},{"nctId":"NCT03469856","phase":"NA","title":"Acetyl Salicylic Elimination Trial: The ASET Pilot Study","status":"UNKNOWN","sponsor":"Pedro A. Lemos","startDate":"2018-02-22","conditions":"Monotherapy After PCI","enrollment":200},{"nctId":"NCT02227368","phase":"PHASE2","title":"Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2014-10-20","conditions":"Peripheral Artery Disease (PAD)","enrollment":40},{"nctId":"NCT03088072","phase":"PHASE4","title":"A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure","status":"UNKNOWN","sponsor":"Scripps Health","startDate":"2017-03-23","conditions":"Non-Valvular Atrial Fibrillation, Left Atrial Appendage Closure","enrollment":75},{"nctId":"NCT02494284","phase":"PHASE4","title":"Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation","status":"TERMINATED","sponsor":"CHEOL WHAN LEE, M.D., Ph.D","startDate":"2015-12-22","conditions":"Coronary Artery Disease","enrollment":364},{"nctId":"NCT02219412","phase":"PHASE4","title":"Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy","status":"COMPLETED","sponsor":"Yong Huo","startDate":"2014-08","conditions":"Coronary Heart Disease","enrollment":70},{"nctId":"NCT02756481","phase":"","title":"Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2013-10","conditions":"Non-Valvular Atrial Fibrillation","enrollment":80},{"nctId":"NCT02618265","phase":"NA","title":"Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2016-01","conditions":"Stroke","enrollment":400},{"nctId":"NCT00822536","phase":"PHASE4","title":"Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-01","conditions":"Coronary Artery Disease, Stent Thrombosis, Myocardial Ischemia","enrollment":1798},{"nctId":"NCT01186146","phase":"PHASE4","title":"Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2010-08","conditions":"Coronary Artery Disease","enrollment":5000},{"nctId":"NCT00590174","phase":"PHASE4","title":"Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation","status":"COMPLETED","sponsor":"Seung-Jung Park","startDate":"2007-10","conditions":"Coronary Artery Disease","enrollment":1175},{"nctId":"NCT01159639","phase":"PHASE4","title":"Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Zagreb","startDate":"2010-06","conditions":"Coronary Artery Disease, Aspirin Resistance","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":164,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Monotherapy"],"phase":"phase_3","status":"active","brandName":"Antiplatelet Monotherapy","genericName":"Antiplatelet Monotherapy","companyName":"Hospital Israelita Albert Einstein","companyId":"hospital-israelita-albert-einstein","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antiplatelet monotherapy inhibits platelet aggregation to reduce thrombotic events. Used for Secondary prevention of cardiovascular events, Acute coronary syndrome, Stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}